Prescription medicine

Technetium tc 99m exametazime Brand names: Ceretec

Technetium tc 99m exametazime (Ceretec) is a prescription medicine. No generic is listed in FDA's NDC Directory.

No generic listed

Check it at the source: the technetium tc 99m exametazime FDA label on DailyMed (effective December 2, 2024); every technetium tc 99m exametazime label on DailyMed.

Highlights of the record

FDA label of December 2, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage
Drax Exametazime is indicated for leukocyte (white blood cell) labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease.

Forms and strengths

0.5 mg
0.5 mg/5ml

Injection (powder) (lyophilized) for solution.

On the market

Generic approvals: No generic approved
Labelers listed (NDC): 2 of which 0 under generic applications, 2 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC): Not in the survey
Shortage (FDA): No current entry
Recalls by its makers (FDA): No recall recorded
FAERS reports: 38 through July 30, 2026

What is technetium tc 99m exametazime used for?

From the label: indications and usage
Drax Exametazime is indicated for leukocyte (white blood cell) labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease. Drax Exametazime is a radioactive diagnostic agent indicated for leukocyte (white blood cell) labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease.

FDA pharmacologic class: Radioactive Diagnostic Agent.

Source: FDA drug label (Drax Exametazime), Jubilant DraxImage Inc., dba Jubilant Radiopharma, effective December 2, 2024 (SPL set fa7811f9-2803-4126-8037-8f3e56462f9c), via openFDA; the full label on DailyMed

Is there a generic for technetium tc 99m exametazime (Ceretec)?

No generic technetium tc 99m exametazime is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the technetium tc 99m exametazime label say about other medicines?

The technetium tc 99m exametazime label names 1 other medicine in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine named	Section	What the label says
Tetrakis copper tetrafluoroborate	warnings and precautions	Radiation Exposure Risk Technetium Tc 99m contributes to a patient’s overall long-term cumulative radiation exposure.

Check technetium tc 99m exametazime against other medicines

What do FAERS reports show for technetium tc 99m exametazime?

The FDA Adverse Event Reporting System holds 38 reports that list technetium tc 99m exametazime among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 3 are coded as a death and 3 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

No Adverse Event (a use or a product term, not a reaction)13
Drug Ineffective (a use or a product term, not a reaction)8
Radioisotope Scan Abnormal7
Rash (named in the label)4
Chills3
Headache (named in the label)3
Condition Aggravated (a use or a product term, not a reaction)2
Dyspnoea2

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What next?

Other radioactive diagnostic agents: the pharmacologic class, with prices and generics
Technetium tc 99m exametazime side effects: the label's list beside FAERS reports
Check an interaction: what two or more labels say about each other